Ninety One (UK)
REGN icon

Ninety One (UK)’s Regeneron Pharmaceuticals REGN Stock Holding History

Ninety One (UK)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
+267
New +$182K ﹤0.01% 237
2025
Q1 		– Sell
-78,005
Closed -$55.6M – 205
2024
Q4 		$55.6M Buy
78,005
+9,820
+14% +$8.24M 0.15% 89
2024
Q3 		$71.7M Buy
68,185
+15,690
+30% +$17.5M 0.19% 82
2024
Q2 		$55.2M Buy
52,495
+10,556
+25% +$10.2M 0.15% 90
2024
Q1 		$40.4M Buy
+41,939
New +$39.9M 0.11% 108

Other funds holding REGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Ninety One (UK)'s REGN Position: Q2 2026 in Review

Ninety One (UK) opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 267 shares worth $166K. The stake represents ﹤0.01% of the portfolio and ranks #237 among its holdings. This is a return to the name: Ninety One (UK) previously reported a position in REGN as recently as Q4 2024.

Ninety One (UK) first reported a position in REGN in Q1 2024 and has held it in 5 quarters since. The position peaked at $71.7M in Q3 2024. 157 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Ninety One (UK) held 267 shares of Regeneron Pharmaceuticals worth $166K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Ninety One (UK) position in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Ninety One (UK)'s portfolio in Q2 2026, its #237 holding.
  • Ninety One (UK) first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • Ninety One (UK)'s Regeneron Pharmaceuticals position peaked at $71.7M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.